About the intiative
The introduction of environmental DNA (eDNA) surveillance is a pivotal advancement with significant implications in the health sector and presents a transformative opportunity for public health monitoring and future pandemic preparedness. As an advanced genomics technique, eDNA surveillance allows for the detection of genetic material shed by organisms into their environment, offering a non-invasive method to assess ecosystem health, track disease-causing pathogens, bolster forensic science capabilities and inform decision-making on public health and related interventions at both a regional and national scale.
When integrated with new technologies, including AI, policymakers will gain valuable insights to predict health outcomes, analyze trends and optimize resource allocations. Machine learning models can also identify patterns, predict disease outbreaks and guide targeted interventions. The rapid identification of disease-causing pathogens will enhance public health preparedness and response, especially during outbreaks or emerging threats. In addition, the environment plays an important role in disease states. The inclusion of eDNA information with available personal health data will improve predictions of health outcomes and develop more comprehensive personalized treatment plans and disease management strategies.
eDNA is emerging as a potent asset in safeguarding both ecosystem and personal health, crucial elements for improving health and well-being and preventing disease in our interconnected world.
Objective
As part of the upcoming Health Initiative, Genome Canada recognizes the important role eDNA will play as a genomic surveillance tool now and in the future. A major barrier to the increased uptake of eDNA as a surveillance tool is the need for more sensitive and accurate detection methods that can differentiate between closely related species.
The primary objective of this initiative is to broaden the use and effectiveness of eDNA surveillance through investments in the development of genomics tools, technologies and solutions that will enable the systematic collection, analysis and interpretation of eDNA samples from various ecosystems across Canada. Special emphasis will be placed on applied eDNA tools that respect and prioritize Indigenous communities’ rights, interests, and expectations, ensuring their needs are met and their active involvement is sought.
A portfolio approach will be used to synergize the deliverables of the eDNA Surveillance Initiative with the broader national outcomes and impacts of Genome Canada’s Health Initiative. Genome Canada will facilitate opportunities to engage and collaborate with other research teams throughout the project term to ensure that the new genomic tools and solutions developed are aligned and well connected to inform public policy decisions. Connectivity with other research teams working on eDNA surveillance regionally, nationally and/or internationally is encouraged.
Three streams of funding
A total of $4.3 million is available from Genome Canada to support the eDNA Surveillance Initiative. There are three streams of funding within this funding opportunity.
STREAM 1 – REGIONAL UPTAKE
Regional Uptake will be Genome Centre led projects aimed at refining eDNA collection methods, improving analytical techniques, and increasing the capacity of eDNA data for public, community and personalized health and biodiversity applications.
STREAM 2 – INDIGENOUS-LED AND/OR PARTNERSHIP-BASED
Indigenous-led and/or partnership-based projects will be aimed at advancing applied eDNA solutions prioritizing Indigenous rights, interests and expectations.
STREAM 3 – COLLABORATION AND ENGAGEMENT
Collaboration and Engagement will be aimed at facilitating discussions with Canadian and International stakeholders with the goals of advancing data standards, implementing best practices, increasing alignment and connectivity and supporting public health and other stakeholders in their decision making.
Available funding, terms and eligibility vary by stream. Please contact your regional Genome Centre for more information.